(Q33800841)

29 July 2017

A novel human IgA monoclonal antibody protects against tuberculosis (English)

1 reference

29 July 2017

0 references

1 reference

1 reference

7

Marjolein van Egmond

0 references

Richard J. Pleass

object named as

Richard J Pleass

4

0 references

Stephen Challacombe

object named as

Stephen Challacombe

8

0 references

Cees van Kooten

6

object named as

Cees van Kooten

1 reference

29 July 2017

Sucharitha Balu

1

1 reference

29 July 2017

Rajko Reljic

2

1 reference

29 July 2017

Melanie J Lewis

3

1 reference

29 July 2017

Richard McIntosh

5

1 reference

29 July 2017

Jenny M Woof

9

1 reference

29 July 2017

Juraj Ivanyi

10

1 reference

29 July 2017

language of work or name

English

0 references

publication date

21 January 2011

1 reference

29 July 2017

Journal of Immunology

1 reference

29 July 2017

186

1 reference

29 July 2017

5

1 reference

29 July 2017

3113-3119

1 reference

describes a project that uses

29 July 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3115510/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Role of IgA and IgA fc receptors in inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Functional and clinical consequences of Fc receptor polymorphic and copy number variants.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Confronting the scientific obstacles to global control of tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Mucosal immunotherapy of tuberculosis: is there a value in passive IgA?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Tuberculosis control in the era of HIV.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

The Fc receptor for IgA (FcalphaRI, CD89)

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Antibody arrays for high-throughput screening of antibody-antigen interactions

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Assessment of immunity to mycobacterial infection with luciferase reporter constructs.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Antibodies: basic mechanisms and emerging concepts.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3115510

Recessive expression of the H2A-controlled immune response phenotype depends critically on antigen dose

30 October 2018

1 reference

12 December 2020

Evaluation of Human Antimycobacterial Immunity Using Recombinant Reporter Mycobacteria

1 reference

12 December 2020

Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition

1 reference

12 December 2020

Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins

1 reference

12 December 2020

The human Fc receptor for IgA (Fc alpha RI, CD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysis

1 reference

12 December 2020

Intranasal IFNgamma extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection

1 reference

12 December 2020

Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice

1 reference

12 December 2020

IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice

1 reference

12 December 2020

Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection

1 reference

12 December 2020

Identifiers

DOI

10.4049/JIMMUNOL.1003189

1 reference

29 July 2017

1 reference

29 July 2017

1 reference